267 related articles for article (PubMed ID: 11773978)
21. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.
Gyorffy S; Palmer K; Gauldie J
Am J Pathol; 2001 Sep; 159(3):1137-47. PubMed ID: 11549607
[TBL] [Abstract][Full Text] [Related]
22. Construction of recombinant lentivirus vector for tumor vasoinhibitory peptide alphastatin gene delivery.
Guo SW; Che HM; Li WZ
Mol Med Rep; 2010; 3(6):923-8. PubMed ID: 21472334
[TBL] [Abstract][Full Text] [Related]
23. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
[TBL] [Abstract][Full Text] [Related]
24. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J
Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714
[TBL] [Abstract][Full Text] [Related]
25. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
26. Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: inhibition of primary tumor growth and metastatic spread.
Cichoń T; Jamrozy L; Glogowska J; Missol-Kolka E; Szala S
Cancer Gene Ther; 2002 Sep; 9(9):771-7. PubMed ID: 12189527
[TBL] [Abstract][Full Text] [Related]
27. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral transfer of the LacZ gene into human endothelial cells and human bone marrow mesenchymal stem cells.
Totsugawa T; Kobayashi N; Okitsu T; Noguchi H; Watanabe T; Matsumura T; Maruyama M; Fujiwara T; Sakaguchi M; Tanaka N
Cell Transplant; 2002; 11(5):481-8. PubMed ID: 12382678
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
[TBL] [Abstract][Full Text] [Related]
30. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
Joki T; Machluf M; Atala A; Zhu J; Seyfried NT; Dunn IF; Abe T; Carroll RS; Black PM
Nat Biotechnol; 2001 Jan; 19(1):35-9. PubMed ID: 11135549
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model.
Li YY; Qian GS; Huang GJ; Chen F; Qian P; Yu SC; Wang CZ; Li Q; Wang JC; Wu GM
Cancer J; 2006; 12(2):136-46. PubMed ID: 16630405
[TBL] [Abstract][Full Text] [Related]
32. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.
Li X; Liu YH; Lee SJ; Gardner TA; Jeng MH; Kao C
Clin Cancer Res; 2008 Jan; 14(1):291-9. PubMed ID: 18172281
[TBL] [Abstract][Full Text] [Related]
33. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
Isayeva T; Chanda D; Kallman L; Eltoum IE; Ponnazhagan S
Cancer Res; 2007 Jun; 67(12):5789-97. PubMed ID: 17575146
[TBL] [Abstract][Full Text] [Related]
34. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells.
Indraccolo S; Morini M; Gola E; Carrozzino F; Habeler W; Minghelli S; Santi L; Chieco-Bianchi L; Cao Y; Albini A; Noonan DM
Cancer Res; 2001 Jul; 61(14):5441-6. PubMed ID: 11454689
[TBL] [Abstract][Full Text] [Related]
35. [Preparation and functional study of an adenovirus vector expressing human plasminogen kringle 5 gene].
Yang J; Wang YX; Guan XQ; Ma CG; Wang LS; Song HY
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):217-22. PubMed ID: 15966325
[TBL] [Abstract][Full Text] [Related]
36. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
[TBL] [Abstract][Full Text] [Related]
37. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
38. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
40. Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice.
Jia S; Zhu F; Li H; He F; Xiu R
Clin Hemorheol Microcirc; 2000; 23(2-4):251-7. PubMed ID: 11321448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
